Aldosterone-producing adenomas: Mining for genes

Hypertension

Volumn 55, Issue 6, 2010, Pages 1306-1307

  Gomez Sanchez, Celso E ^a   Gomez Sanchez, Elise P ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR; NODAL SIGNALING PROTEIN; TERATOCARCINOMA DERIVED GROWTH FACTOR 1; UNCLASSIFIED DRUG;

ADRENAL CORTEX ADENOMA; ADRENALECTOMY; ALDOSTERONE PRODUCING ADENOMA; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE CLASSIFICATION; DNA MICROARRAY; ENZYME LOCALIZATION; GENE CONTROL; GENE EXPRESSION; GENETIC IDENTIFICATION; GENOME ANALYSIS; HISTOPATHOLOGY; HUMAN; HYPERTENSION; IN SITU HYBRIDIZATION; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; ZONA GLOMERULOSA;

ADENOMA; ADRENAL CORTEX NEOPLASMS; ALDOSTERONE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; HYPERALDOSTERONISM; MALE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 77952950711     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.151480     Document Type: Note

References (12)

1. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Sto-wasser M, Young WF Jr, Montori VM. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:3266-3281.
2. Gomez-Sanchez CE, Rossi GP, Fallo F, Mannelli M. Progress in primary aldosteronism: present challenges and perspectives. Horm Metab Res. 2010 [Epub ahead of print].
3. Conn JW. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med. 1955;45:3-7.
4. Neville AM, O'Hare MJ. Histopathology of the human adrenal cortex. Clin Endocrinol Metab. 1985;14:791-820.
5. Enberg U, Volpe C, Hoog A, Wedell A, Farnebo LO, Thoren M, Hamberger B. Postoperative differentiation between unilateral adrenal adenoma and bilateral adrenal hyperplasia in primary aldosteronism by mRNA expression of the gene CY11B2. Eur J Endocrinol. 2004;151:73-85.
6. Sukor N, Gordon RD, Ku YK, Jones M, Stowasser M. Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience. J Clin Endocrinol Metab. 2009;94:2437-2445.
7. Lenzini L, Seccia TM, Aldighieri E, Belloni AS, Bernante P, Giuliani L, Nussdorfer GG, Pessina AC, Rossi GP. Heterogeneity of aldoste-rone-producing adenomas revealed by a whole transcriptome analysis. Hypertension. 2007;50:1106-1113.
8. Ye P, Mariniello B, Mantero F, Shibata H, Rainey WE. G-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronism. J Endocrinol. 2007;195:39-48.
9. Assie G, Auzan C, Gasc JM, Baviera E, Balaton A, Elalouf JM, Jeun-emaitre X, Plouin PF, Corvol P, Clauser E. Steroidogenesis in aldoste-rone-producing adenoma revisited by transcriptome analysis. J Clin Endocrinol Metab. 2005;90:6638-6649.
10. Williams TA, Monticone S, Morello F, Liew C-C, Mengozzi G, Pilon C, Asioli S, Sapino A, Veglio F, Mulatero P. Teratocarcinoma-derived growth factor-1 is upregulated in aldosterone-producing adenomas and increases aldosterone secretion and inhibits apoptosis in vitro. Hypertension. 2010;55: 1468-1475.
11. Adamson ED, Minchiotti G, Salomon DS. Cripto: a tumor growth factor and more. J Cell Physiol. 2002;190:267-278.
12. Bianco C, Mysliwiec M, Watanabe K, Mancino M, Nagaoka T, Gonzales M, Salomon DS. Activation of a Nodal-independent signaling pathway by Cripto-1 mutants with impaired activation of a Nodal-dependent signaling pathway. FEBS Lett. 2008;582:3997-4002.